Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease

Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis

(2011) Akio Kawakami et al.   Journal of Atherosclerosis and Thrombosis

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins

(2009) Carlos O. Mendivil et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

(2009) A. Hiukka et al.   DIABETES

Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction

(2008) Akio Kawakami et al.   CIRCULATION

Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted

(2008) Akio Kawakami et al.   CIRCULATION RESEARCH

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

(2008) Esther M. M. Ooi et al.   CLINICAL SCIENCE

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

(2008) T. I. Pollin et al.   SCIENCE